Hypofractionated Radiotherapy with Sequential Anthracycline-based Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Final Results of a Phase II Clinical Trial

被引：0
|
作者：
Spalek, M. [1 ]
Kosela-Paterczyk, H. [1 ]
Borkowska, A. [1 ]
Wagrodzki, M. [2 ]
Szumera-Cieckiewicz, A. [2 ]
Czarnecka, A. M. [1 ,3 ]
Castaneda-Wysocka, P. [4 ]
Dabrowska-Szewczyk, E. [5 ]
Cieszanowski, A. [4 ]
Rutkowski, P. [1 ]
机构：
[1] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Soft Tissue Bone Sarcoma & Melanoma, Warsaw, Poland
[2] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Pathol, Warsaw, Poland
[3] Polish Acad Sci, Dept Expt Pharmacol, Mossakowski Med Res Ctr, Warsaw, Poland
[4] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Radiol 1, Warsaw, Poland
[5] Maria Sklodowska Curie Natl Res Inst Oncol, Dept Med Phys, Warsaw, Poland
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2020年 / 108卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1031
引用
收藏
页码：S131 / S131
页数：1
相关论文
共 50 条
  • [1] Combined Preoperative Hypofractionated Radiotherapy With Doxorubicin-Ifosfamide Chemotherapy in Marginally Resectable Soft Tissue Sarcomas: Results of a Phase 2 Clinical Trial
    Spalek, Mateusz J.
    Kosela-Paterczyk, Hanna
    Borkowska, Aneta
    Wagrodzki, Michal
    Szumera-Cieckiewicz, Anna
    Czarnecka, Anna M.
    Castaneda-Wysocka, Patricia
    Kalinowska, Iwona
    Poleszczuk, Jan
    Dabrowska-Szewczyk, Edyta
    Cieszanowski, Andrzej
    Rutkowski, Piotr
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 110 (04): : 1053 - 1063
  • [2] Preoperative hypofractionated radiotherapy (RT) combined with chemotherapy in primary marginally resectable high grade soft tissue sarcomas (STS) of extremities or trunk wall: Interim analysis of prospective phase II clinical trial
    Spalek, M.
    Paterczyk, H. M. Kosela
    Borkowska, A.
    Wagrodzki, M.
    Cieszanowski, A.
    Castaneda-Wysocka, P.
    Switaj, T.
    Dudzisz-Sledz, M. E.
    Czarnecka, A. M.
    Dabrowska-Szewczyk, E.
    Rutkowski, P. L.
    ANNALS OF ONCOLOGY, 2018, 29 : 585 - 586
  • [3] Phase II prospective study with sorafenib in advanced soft tissue sarcomas after anthracycline-based therapy
    Santoro, A.
    Comandone, A.
    Basso, U.
    Parra, H. Soto
    De Sanctis, R.
    Stroppa, E.
    Marcon, I.
    Giordano, L.
    Lutman, F. R.
    Boglione, A.
    Bertuzzi, A.
    ANNALS OF ONCOLOGY, 2013, 24 (04) : 1093 - 1098
  • [4] PHASE II STUDY OF NEOADJUVANT BEVACIZUMAB AND RADIOTHERAPY FOR RESECTABLE SOFT TISSUE SARCOMAS
    Yoon, Sam S.
    Duda, Dan G.
    Karl, Daniel L.
    Kim, Tae-Min
    Kambadakone, Avinash R.
    Chen, Yen-Lin
    Rothrock, Courtney
    Rosenberg, Andrew E.
    Nielsen, G. Petur
    Kirsch, David G.
    Choy, Edwin
    Harmon, David C.
    Hornicek, Francis J.
    Dreyfuss, Jonathan
    Ancukiewicz, Marek
    Sahani, Dushyant V.
    Park, Peter J.
    Jain, Rakesh K.
    DeLaney, Thomas F.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2011, 81 (04): : 1081 - 1090
  • [5] Phase II study of intravenous TZT-1027 in patients with advanced or metastatic soft-tissue sarcomas with prior exposure to anthracycline-based chemotherapy
    Patel, Shreyaskumar
    Keohan, Mary Louise
    Saif, M. Wasif
    Rushing, Daniel
    Baez, Luis
    Feit, Kevie
    DeJager, Robert
    Anderson, Sibyl
    CANCER, 2006, 107 (12) : 2881 - 2887
  • [6] Topoisomerase IIα expression and response to anthracycline-based neoadjuvant chemotherapy:: Results from a randomized clinical trial
    Schwartz, R
    Schnitt, S
    Rousseau, A
    Diéras, V
    Couturier, J
    de Crémoux, P
    Pliss, N
    Sastre-Garau, X
    Vincent-Salomon, A
    LABORATORY INVESTIGATION, 2003, 83 (01) : 46A - 46A
  • [7] Topoisomerase IIα expression and response to anthracycline-based neoadjuvant chemotherapy:: Results from a randomized clinical trial
    Schwartz, R
    Schnitt, S
    Rousseau, A
    Diéras, V
    Couturier, I
    de Crémoux, P
    Pliss, N
    Sastre-Garau, X
    Vincent-Salomon, A
    MODERN PATHOLOGY, 2003, 16 (01) : 46A - 46A
  • [8] Neoadjuvant hypofractionated radiotherapy and chemotherapy for extremity soft tissue sarcomas: Safety, feasibility, and early oncologic outcomes of a phase 2 trial
    Silva, Maria Leticia Gobo
    de Mello, Celso Abdon Lopes
    Aguiar Junior, Samuel
    Costa, Felipe D'Almeida
    Filho, Paulo Roberto Stevanato
    Bezerra, Tiago Santoro
    Nakagawa, Suely Akiko
    Nascimento, Antonio Geraldo
    da Cunha, Isabela Werneck
    Batista, Ranyell Matheus Spencer Sobreira
    Daher, Ulisses Ribaldo Nicolau
    Formiga, Maria Nirvana Da Cruz
    Germano, Janaina Naiara
    Kupper, Bruna Elisa Catin
    Pellizzon, Antonio Cassio De Assis
    Lopes, Ademar
    RADIOTHERAPY AND ONCOLOGY, 2021, 159 : 161 - 167
  • [9] Preoperative Hypofractionated Radiotherapy with Locoregional Hyperthermia in Recurrent and Radiation-Associated Sarcomas: Final Results of a Phase 2 Clinical Trial
    Spalek, M. J.
    Borkowska, A.
    Telejko, M.
    Rutkowski, P.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : S181 - S181
  • [10] Gemcitabine and vinorelbine combination chemotherapy for patients with advanced soft tissue sarcomas - Results of a phase II trial
    Dileo, Palma
    Morgan, Jeffrey A.
    Zahrieh, David
    Desai, Jayesh
    Salesi, Jeanine M.
    Harrnon, David C.
    Quigley, M. Travis
    Polson, Kathleen
    Demetri, George D.
    George, Suzanne
    CANCER, 2007, 109 (09) : 1863 - 1869
12345